The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

has sued the top three pharmacy benefit managers (PBMs) in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices of insulin products. The lawsuit ...

The 'big three' insulin producers Novo ... to set artificially inflated prices for their products. The lawsuit also takes aim at the three largest pharmacy benefit managers (PBMs) in the US ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s ...

Therefore, entities like insurance companies and TPAs often outsource the management of pharmacy benefits to one of the major PBMs. [27] TPAs are independent benefit ... to put prices on a level ...

As former President Donald Trump has clinched a second term with a victory, his health care priorities will differ somewhat from his first term, ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access. Novo Nordisk's production shift raises concerns as diabetes cases rise, ...

This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...

Yes. In 2020, President Donald Trump put in a voluntary Insulin Price Cap, which most insurance carriers followed through ...

Indeed, insulin prices have skyrocketed. One variety—Humalog—though ... if individuals were free to purchase insulin themselves rather than through a licensed pharmacy and with a prescription from a ...